Recent Advance in Aminopeptidase N (APN/CD13) Inhibitor Research

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|18|32|5011-5021

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.18, Iss.32, 2011-11, pp. : 5011-5021

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Aminopeptidase N (APN/CD13) as a Target for Anti-Cancer Agent Design

By  

Current Medicinal Chemistry, Vol. 15, Iss. 27, 2008-11 ,pp. : 2850-2865

Bentham Science Publishers

Access to resources Recommend Favorite

The Synthesis and Activity Evaluation of a Bestatin Derivative (LYP) as an Aminopeptidase N Inhibitor

By  

Letters in Drug Design & Discovery, Vol. 6, Iss. 6, 2009-09 ,pp. : 420-423

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Advance in the Research of Flavonoids as Anticancer Agents

By  

Mini Reviews in Medicinal Chemistry, Vol. 7, Iss. 7, 2007-07 ,pp. : 663-678

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Development of Peptide Drugs and Advance on Theory and Methodology of Peptide Inhibitor Design

By  

Medicinal Chemistry, Vol. 11, Iss. 3, 2015-05 ,pp. : 235-247

Bentham Science Publishers

Access to resources Recommend Favorite

Leucine Aminopeptidase as a Target for Inhibitor Design

By  

Mini Reviews in Medicinal Chemistry, Vol. 1, Iss. 2, 2001-07 ,pp. : 133-144

Bentham Science Publishers

Access to resources Recommend Favorite